Information Journal Paper
APA:
Copy. (2017). Neoadjuvant therapy in patients with triple negative and HER2 positive early breast cancer. BREAST, 32(-), 0-0. SID. https://sid.ir/paper/772959/en
Vancouver:
Copy. Neoadjuvant therapy in patients with triple negative and HER2 positive early breast cancer. BREAST[Internet]. 2017;32(-):0-0. Available from: https://sid.ir/paper/772959/en
IEEE:
Copy, “Neoadjuvant therapy in patients with triple negative and HER2 positive early breast cancer,” BREAST, vol. 32, no. -, pp. 0–0, 2017, [Online]. Available: https://sid.ir/paper/772959/en